Related Experiment Video

Updated: May 11, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Strategies to reduce hepatitis C virus recurrence after liver transplantation

Ruben Ciria1, María Pleguezuelo, Shirin Elizabeth Khorsandi

  • 1Ruben Ciria, Shirin Elizabeth Khorsandi, Diego Davila, Abid Suddle, Hector Vilca-Melendez, Nigel Heaton, Institute of Liver Studies, King's College Hospital, London SE5 9RS, United Kingdom.

World Journal of Hepatology
|May 30, 2013
PubMed

Insights

Hepatitis C virus (HCV) recurrence post-liver transplant is common and accelerates graft damage. Strategies targeting pre-transplant, transplant, and post-transplant phases can mitigate HCV recurrence and improve patient outcomes.

Area of Science:

  • Hepatology
  • Transplantation Immunology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma, frequently necessitating liver transplantation.
  • HCV invariably re-infects liver grafts post-transplantation, leading to rapid recurrence, cirrhosis within five years, and poorer patient/graft survival.
  • The high rate of HCV recurrence challenges transplant outcomes and graft utilization, prompting research into effective management strategies.

Purpose of the Study:

  • To provide a comprehensive overview of post-transplant HCV recurrence.
  • To explore strategies for reducing the impact of HCV recurrence on liver transplant recipients.
  • To guide clinicians in managing HCV recurrence by examining interventions at different stages of the transplant process.

Main Methods:

  • This review synthesizes current literature on Hepatitis C virus recurrence after liver transplantation.
  • It analyzes factors influencing recurrence risk, including pre-transplant viral load, donor characteristics, and ischemia-reperfusion injury.
  • The review discusses post-transplant management options, focusing on immunosuppression and antiviral therapy timing.

Main Results:

  • HCV recurrence post-liver transplant is nearly universal and associated with accelerated graft damage and cirrhosis.
  • Factors such as donor age, graft steatosis, and ischemia/reperfusion injury may increase recurrence severity.
  • Optimizing immunosuppression and timing of antiviral treatment (prophylactic, pre-emptive, or on-demand) are key areas for intervention.

Conclusions:

  • Effective management of HCV recurrence is crucial for improving outcomes in liver transplant recipients.
  • Interventions targeting pre-transplant, peri-transplant, and post-transplant periods hold promise for reducing recurrence impact.
  • Further research is needed to establish long-term benefits of pre-transplant viral load reduction and optimize post-transplant treatment protocols.

Keywords:
Hepatitis C virusLiverOutcomesRecurrenceTransplantation

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...